New publication on treatment and diagnosis of diabetes mellitus in Africa
This systematic review from our Ugandan PROTID colleagues demonstrates that the availability of essential medicines and diagnostic tests for diabetes in Africa is suboptimal. The relatively high cost of insulin, HbA1c, and lipid profile tests forms a significant barrier to optimal diabetes care. The article advocates pragmatic country-specific strategies to address these inequities in access and cost.
Access the full text via the below link:
Availability and affordability of essential medicines and diagnostic tests for diabetes mellitus in Africa – Kibirige – 2022 – Tropical Medicine & International Health – Wiley Online Library
This project is part of the EDCTP2 programme supported by the European Union (grant number RIA2018CO-2514).